Blinatumomab Followed by High-dose Chemotherapy for Ph-negative Acute Lymphoblastic Leukemia (ALL)

Clinical trial NCT04554485 · COMPLETED

Trial details

NCT number: NCT04554485
Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoblastic Leukemia, Acute, Adult Ph Negative ALL Newly Diagnosed

Start date: 2019-05-09
Primary completion: 2024-02-29
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.